Isoray Reschedules Fourth Quarter and Fiscal Year End 2021 Financial Results Conference Call to September 22, 2021 Due to Conference Provider Technical Issues
September 21, 2021 18:59 ET
|
Isoray, Inc.
RICHLAND, Wash., Sept. 21, 2021 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in brachytherapy powering expanding treatment options throughout the...
Isoray Announces Fourth Quarter and Full-Year Fiscal Year End 2021 Financial Results
September 21, 2021 16:05 ET
|
Isoray, Inc.
Record Full Year RevenueFiscal Fourth Quarter Revenue Increased 19% Year-Over-Year RICHLAND, Wash., Sept. 21, 2021 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology...
Isoray To Announce Fourth Quarter and Fiscal Year End 2021 Financial Results on September 21, 2021
September 09, 2021 08:13 ET
|
Isoray, Inc.
RICHLAND, Wash, Sept. 09, 2021 (GLOBE NEWSWIRE) -- – Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in brachytherapy powering expanding treatment options throughout...
Isoray Announces Third Quarter Fiscal 2021 Financial Results
May 13, 2021 16:05 ET
|
Isoray, Inc.
Revenue Increased 10% Sequentially Record Non-Prostate Brachytherapy Revenue Increased 20% Year-Over-Year RICHLAND, Wash., May 13, 2021 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a...
Isoray To Announce Third Quarter Fiscal 2021 Financial Results on May 13, 2021
April 29, 2021 08:13 ET
|
Isoray, Inc.
RICHLAND, Wash., April 29, 2021 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in brachytherapy powering expanding treatment options throughout...
Isoray Announces the Appointment of Donna Fort as Vice President Sales and Marketing
April 13, 2021 08:13 ET
|
Isoray, Inc.
RICHLAND, Wash., April 13, 2021 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE American: ISR), a medical technology company and seed brachytherapy innovator, today announced that Donna Fort has been...
University Hospitals Cleveland Medical Center Pilot Study Shows Promise for High-Risk Recurrent Head and Neck Cancer Treatment with Cesium-131 and Surgical Resection
March 31, 2021 08:13 ET
|
Isoray, Inc.
RICHLAND, Wash., March 31, 2021 (GLOBE NEWSWIRE) -- A recently published small prospective series of patients with recurrent head and neck (H&N) cancers treated with surgical resection and...
Isoray to Present at the Oppenheimer 31st Annual Healthcare Conference
March 03, 2021 08:13 ET
|
Isoray, Inc.
RICHLAND, Wash., March 03, 2021 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE American: ISR), a medical technology company and seed brachytherapy innovator, today announced that Chief Executive Officer...
Isoray Announces the Appointment of Lisa Lauer As Vice President Business Development
February 16, 2021 08:13 ET
|
Isoray, Inc.
RICHLAND, Wash., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE American: ISR), a medical technology company and seed brachytherapy innovator, today announced that Lisa Lauer has been...
Isoray Announces Second Quarter Fiscal 2021 Financial Results
February 09, 2021 16:06 ET
|
Isoray, Inc.
Revenue Increased 7% Year-Over-YearNon-Prostate Brachytherapy Revenue Increased 92% Year-Over-Year RICHLAND, Wash., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical...